Turner syndrome, insulin sensitivity and growth hormone treatment

Hormone Research

Volumn 64, Issue SUPPL. 3, 2005, Pages 51-57

  Mazzanti, Laura ^a   Bergamaschi, Rosalba ^a   Castiglioni, Laura ^a   Zappulla, Franco ^a   Pirazzoli, Piero ^a   Cicognani, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Children; Growth hormone; Insulin resistance; Insulin sensitivity; Turner syndrome

Indexed keywords

GROWTH HORMONE; TRIACYLGLYCEROL;

ADOLESCENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARBOHYDRATE TOLERANCE; CATCH UP GROWTH; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FOLLOW UP; HORMONAL THERAPY; HUMAN; INSULIN SENSITIVITY; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; TURNER SYNDROME;

ADOLESCENT; ADULT; AGE FACTORS; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; TRIGLYCERIDES; TURNER SYNDROME;

EID: 31544434538     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089318     Document Type: Conference Paper

References (26)

1. Bernasconi S, Larizza D, Benso L, Volta C, Vannelli S, Milani S, Aicardi G, Berardi R, Borrelli P, Boscherini B, et al: Turner's syndrome in Italy: familial characteristics, neonatal data, standards for birth weight and for height and weight from infancy to adulthood. Acta Paediatr 1994;83:292-298.
2. Ranke MB, Pfluger H, Rosendhal W, Strubbe P, Enders H, Bierich JR, Majewski F: Turner syndrome: spontaneous growth in 150 cases and review of the literature. Eur J Pediatr 1983;141:81-88.
3. Pirazzoli P, Mazzanti L, Bergamaschi R, Perri A, Scarano E, Nanni S, Zucchini S, Gualandi S, Cicognani A, Cacciari E: Reduced spontaneous growth hormone secretion in patients with Turner's syndrome. Acta Paediatr 1999;88:610-613.
4. Cavallo L, Gurrado R; and the Italian Study Group for Turner Syndrome: Endogenous growth hormone secretion does not correlate with growth in patients with Turner's syndrome. J Pediatr Endocrinol Metab 1999;12:623-627.
5. Cacciari E, Mazzanti L: Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome. J Clin Endocrinol Metab 1999;84:4510-4515.
6. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL: Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab 1999;84:4607-4612.
7. Saenger P: Metabolic consequences of growth hormone treatment in paediatric practice. Horm Res 2000;53(suppl 1):60-69.
8. Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, Price DA: Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 2000;355:610-613.
9. Cicognani A, Mazzanti L, Tassinari D, Pellacani A, Forabosco A, Landi L, Pifferi C, Cacciari E: Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Eur J Pediatr 1988;48:64-68.
10. Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV: Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab 1991;72:832-836.
11. Gravholt CH, Juul S, Naeraa RW, Hansen J: Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-158.
12. Wilson DM, Frane JW, Sherman B, Johanson AJ, Hintz RL, Rosenfeld RG: Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both. J Pediatr 1988;112:210-217.
13. Caprio S, Boulware SD, Press M, Sherwin RS, Rubin K, Carpenter TO, Plewe G, Tamborlane WV: Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome. J Pediatr 1992;120:238-243.
14. Weise M, James D, Hartmann KH, Reinhardt D, Leitner C, Bohles HJ, Attanasio A: Dose-dependent effect of growth hormone therapy on glucose metabolism in subjects with Turner syndrome. The German Lilly Ullrich-Turner Syndrome Study Group. Horm Res 1993;39(suppl 2):25-29.
15. Monti LD, Brambilla P, Caumo A, Magni F, Omati S, Nizzoli G, di Natale B, Galli-Kienle M, Cobelli C, Chiumello G, Pozza G: Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome. Metabolism 1997;46:1482-1488.
16. Van Pareren YK, De Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Drop SL; and the Dutch Advisory Group on GH: Effect of discontinuation of long-term GH treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol Metab 2002;87:5442-5448.
17. Radetti G, Pasquino B, Gottardi E, Boscolo Contadin I, Amaretti G, Rigon F: Insulin sensitivity in Turner's syndrome: influence of GH treatment. J Endocrinol 2004;151:351-354.
18. Albareda M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R: Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000;43:1507-1511.
19. Pacini G, Mari A: Methods for clinical assessment of insulin sensitivity and β-cell function. Best Pract Res Clin Endocrinol Metab 2003;17:305-322.
20. Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S: Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004;89:1096-1101.
21. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462-1470.
22. Schwartz RA: Acanthosis nigricans. J Am Acad Dermatol 1994;31:1-19.
23. Elsheikh M, Conway GS: The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol 1998;49:447-450.
24. Bergman RN, Zaccaro DJ, Watanabe RM, Haffner SM, Saad MF, Norris JM, Wagenknecht LE, Hokanson JE, Rotter JI, Rich SS: Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 2003;52:2168-2174.
25. Mazzanti L, Cacciari E, Bergamaschi R, Tassinari D, Magnani C, Perri A, Scarano E, Pluchinotta V: Pelvic ultrasonography in patients with Turner syndrome: age-related findings in different karyotypes. J Pediatr 1997;131:135-140.
26. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G: Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. J Clin Endocrinol Metab 1997;82:1810-1813.